UroGen settles Jelmyto patent suit with Teva, generic entry set for September 2030
Filed June 2, 2026 · Period ending June 2, 2026 · ~1 min read
3 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade URGN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 3, 2026 3:54 PM